Allergy & Immunology Scribe: 95165 and Modifier 25

Why Allergy Visits Need Two Documentation Tracks

Allergy and immunology visits rarely serve a single purpose. A patient who arrives for a maintenance injection may also describe three weeks of nocturnal cough, heavier rescue inhaler use, or hives after the last dose. The vial room conversation and the clinical conversation happen in one encounter. Payers still expect them to read as two distinct services. When a note blends them, modifier 25 loses its support.

Merry treats every allergy encounter as two parallel documentation tracks. Dialogue about antigen selection, dilution, and dose volume goes to the immunotherapy record. Dialogue about new symptoms, exam findings, and management changes goes to the evaluation and management section. The clinician reviews both before anything reaches the chart.

Immunotherapy Preparation Under CPT 95165

CPT 95165 covers the supervision of preparation and provision of non-venom antigens in multidose vials. That service includes the physician's calculations of concentration and volume from prior skin testing and history. It does not include administration. Injections are reported separately with 95115 for a single injection or 95117 for two or more. For Medicare, each billable dose is a 1 cc aliquot, so a vial filled to 6 cc reports six units.

Payer guidance from AAAAI and ACAAI asks for four elements: the physician who established the plan, the clinical indication, the date the plan was formulated, and the patient's response at each routine visit. Merry captures these as discrete fields so continued medical necessity is easy to see. Informed consent is part of the immunotherapy service and never supports a separate E/M.

The Separately Identifiable E/M Narrative

A defensible modifier 25 claim depends on a new problem or a real change in management. Merry isolates findings such as a falling Asthma Control Test score, acute sinusitis, an oversized local reaction, or medication intolerance. It drafts them under an 'E/M – New Symptoms & Plan Change' header, with their own history, examination, and medical decision making.

Routine shot logistics stay out of this section. Pre-injection peak flow checks, the standard 30-minute observation, and vial labeling are part of the procedure. Modifier 59 and its X-subtypes are reserved for distinct procedures and are never appended to an E/M line.

The Allergy Clinical Logic Matrix

Each row below pairs a diagnostic indicator with the data Merry extracts and the billing evidence it supports. Full code descriptors are available at https://www.ama-assn.org/practice-management/cpt.

Allergy testing and immunotherapy are not reported on the same date under Medicare billing guidance. Merry flags transcripts that contain both so the clinician can correct the encounter before signing.

Chrome Extension Routing in the Allergy Clinic Tab

The Merry Chrome Extension pins to the allergy clinic tab of your web EHR. It works whether injection schedules live in a dedicated immunotherapy module or a procedure template. It reads section labels in the active window, including embedded iframes. Before writing anything, it confirms which fields belong to the visit note and which belong to the procedure record.

Routing rules are deliberately conservative. E/M narrative is injected only when an office or outpatient E/M code is configured for the encounter. Immunotherapy content is injected only when 95165, 95115, or 95117 is on the procedure list. Each write triggers the same input events as manual typing, which preserves version history. Nothing is written into a signed or locked note.

Vial and Dosing Summary on Confirm

When the clinician presses confirm, Merry injects a compact vial and dosing summary into the immunotherapy section. It includes antigen mix, concentration, vial identifier, expiration, aliquot count, injection volume, phase, and any dose hold with its reason. The summary is tied to the encounter ID, so a page refresh never duplicates content.

Prompt packs for build-up schedules, maintenance visits, cluster protocols, and reaction follow-ups are available at https://templates.scribing.io. Each pack keeps the same two-track structure.

Longitudinal Complexity and Audit Readiness

HCPCS G2211 recognizes the continuing relationship between an allergist and a patient whose asthma or allergic rhinitis is managed over years. Merry surfaces longitudinal markers in the E/M section: control trajectory, comorbid chronic rhinosinusitis, biologic eligibility, and follow-up strategy.

Payer rules here require care. Under current Medicare policy, G2211 is payable with a modifier 25 E/M only when the same-day service is an annual wellness visit, vaccine administration, or Part B preventive service. Allergen immunotherapy is not on that list. On injection days, Merry presents G2211 as a review prompt for your coder rather than a suggestion.

Every note remains clinician-authored and clinician-signed. Merry labels generated content according to your organization's policy. The allergist keeps full control to accept, edit, or delete each section before signing.